New Drug Approvals Archive
New Drug Approvals: February 2009
| February 5 | Isentress (raltegravir)
Labeling Revision Approved: January 29, 2009 HIV/AIDS Update - Traditional Approval of Isentress (raltegravir) |
| February 6 | ATryn (Antithrombin (Recombinant)) Date of Approval: February 6, 2009 Company: GTC Biotherapeutics, Inc. Treatment for: Antithrombin III Deficiency ATryn (Antithrombin (Recombinant)) is a recombinant form of human antithrombin for the prevention of peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients. ATryn (Antithrombin [Recombinant]) Approved by the FDA |
| February 13 | Uloric (febuxostat) Tablets Date of Approval: February 13, 2009 Company: Takeda Pharmaceutical Company Limited Treatment for: Gout Uloric (febuxostat) is a xanthine oxidase inhibitor indicated for the chronic management of hyperuricemia in patients with gout. FDA Approves Uloric (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout |
| February 26 | Apidra (insulin glulisine)
New Dosage Form Approved: February 24, 2009 FDA Approves Apidra SoloSTAR - a Prefilled Disposable Insulin Pen |
| February 27 | Symbicort (budesonide and formoterol)
New Indication Approved: February 27, 2009 FDA Approves Symbicort for Chronic Obstructive Pulmonary Disease (COPD) |
New Drug Approvals Archive
2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Feb | Jul | Aug | Oct | Nov | Dec
